• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化急性加重的预后分类:一项多中心回顾性队列研究。

Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study.

机构信息

Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama Higashiku, Hamamatsu, 431-3192, Japan.

Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.

出版信息

Sci Rep. 2021 Apr 27;11(1):9120. doi: 10.1038/s41598-021-88718-2.

DOI:10.1038/s41598-021-88718-2
PMID:33907284
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8079397/
Abstract

Acute exacerbation (AE) in idiopathic pulmonary fibrosis (IPF) is a major prognostic determinant. However, evidence for its prognostic strength is mainly based on the results of small cohort studies with statistical limitations. This retrospective study, which included 108 patients with a first episode of AE-IPF, aimed to identify prognostic factors and to develop prognostic classification models. Multivariate Cox regression analysis revealed that a lower percent-predicted forced vital capacity within 12 months before AE onset (baseline %FVC) and a lower PaO/FiO ratio at AE onset were independent mortality predictors. If the value of each predictor was lower than the cutoff determined by receiver-operating characteristic analysis, 1 point was assigned. Classification of patients into mild, moderate, and severe groups based on total score showed post-AE 90-day cumulative survival rates of 83.3%, 66.2%, and 22.2%, respectively (model 1: C-index 0.702). Moreover, a decision tree-based model was created with the recursive partitioning method using baseline %FVC and PaO/FiO ratio at AE onset from among multivariable; accordingly, patients were classified into 3 groups with post-AE 90-day cumulative survival rates of 84.1%, 64.3%, and 24.0%, respectively (model 2: C-index 0.735). These models can guide clinicians in determining therapeutic strategies and help design future studies on AE-IPF.

摘要

特发性肺纤维化(IPF)急性加重(AE)是一个主要的预后决定因素。然而,其预后强度的证据主要基于具有统计学局限性的小队列研究结果。本回顾性研究纳入了 108 例首次发生 AE-IPF 的患者,旨在确定预后因素并建立预后分类模型。多变量 Cox 回归分析显示,AE 发作前 12 个月内预计用力肺活量的百分比(基线%FVC)较低和 AE 发作时 PaO/FiO 比值较低是独立的死亡预测因素。如果每个预测因素的值低于通过接收者操作特征分析确定的截定点,则赋值 1 分。基于总分将患者分为轻度、中度和重度组,AE 后 90 天的累积生存率分别为 83.3%、66.2%和 22.2%(模型 1:C 指数 0.702)。此外,还使用基线%FVC 和 AE 发作时的 PaO/FiO 比值通过递归分区方法从多变量中创建了一个基于决策树的模型;因此,患者被分为 3 组,AE 后 90 天的累积生存率分别为 84.1%、64.3%和 24.0%(模型 2:C 指数 0.735)。这些模型可以指导临床医生确定治疗策略,并有助于设计未来的 AE-IPF 研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4020/8079397/a8e975e5c97a/41598_2021_88718_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4020/8079397/6d7464c0c7ea/41598_2021_88718_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4020/8079397/e7b5d7604d1b/41598_2021_88718_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4020/8079397/6212f13cb09f/41598_2021_88718_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4020/8079397/a8e975e5c97a/41598_2021_88718_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4020/8079397/6d7464c0c7ea/41598_2021_88718_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4020/8079397/e7b5d7604d1b/41598_2021_88718_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4020/8079397/6212f13cb09f/41598_2021_88718_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4020/8079397/a8e975e5c97a/41598_2021_88718_Fig4_HTML.jpg

相似文献

1
Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study.特发性肺纤维化急性加重的预后分类:一项多中心回顾性队列研究。
Sci Rep. 2021 Apr 27;11(1):9120. doi: 10.1038/s41598-021-88718-2.
2
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.类风湿关节炎相关间质性肺疾病急性加重:死亡率及其预测模型。
Respir Res. 2022 Mar 11;23(1):57. doi: 10.1186/s12931-022-01978-y.
3
Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.特发性间质性肺炎未分类急性加重:与特发性肺纤维化的比较。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620935774. doi: 10.1177/1753466620935774.
4
Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.血清铁蛋白在特发性肺纤维化急性加重期的预后评估
Clin Respir J. 2018 Aug;12(8):2378-2389. doi: 10.1111/crj.12918.
5
Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.呼气末正压通气氧合对特发性肺纤维化急性加重期的预后评估:一项回顾性队列研究
Clin Respir J. 2018 Mar;12(3):895-903. doi: 10.1111/crj.12602. Epub 2017 Jan 12.
6
Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.特发性肺纤维化急性呼吸恶化新分类的结果。
Respir Med. 2018 Oct;143:147-152. doi: 10.1016/j.rmed.2018.09.011. Epub 2018 Sep 13.
7
Acute exacerbation of idiopathic pulmonary fibrosis: usual interstitial pneumonitis vs. possible usual interstitial pneumonitis pattern.特发性肺纤维化急性加重:普通型间质性肺炎与可能的普通型间质性肺炎模式。
Chin Med J (Engl). 2019 Sep 20;132(18):2177-2184. doi: 10.1097/CM9.0000000000000422.
8
New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis.新型风险评分系统预测特发性肺纤维化急性加重后 3 个月的死亡率。
Sci Rep. 2022 Jan 21;12(1):1134. doi: 10.1038/s41598-022-05138-6.
9
Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.改良 GAP 指数预测非小细胞肺癌合并特发性肺纤维化急性加重
Respirology. 2017 Oct;22(7):1379-1385. doi: 10.1111/resp.13075. Epub 2017 May 23.
10
Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.特发性肺纤维化初始评估中肺动脉高压作为预后指标。
Respiration. 2013;85(6):456-63. doi: 10.1159/000345221. Epub 2012 Dec 19.

引用本文的文献

1
Acute exacerbation of idiopathic pulmonary fibrosis a narrative review primary focus on treatments.特发性肺纤维化急性加重:一项主要关注治疗的叙述性综述
J Thorac Dis. 2024 Jul 30;16(7):4727-4741. doi: 10.21037/jtd-23-1565. Epub 2024 Jul 11.
2
Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases.特发性肺纤维化及其他间质性肺疾病急性加重住院患者的临床表现和预后因素分析。
BMJ Open Respir Res. 2024 Feb 27;11(1):e001997. doi: 10.1136/bmjresp-2023-001997.
3
Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.

本文引用的文献

1
Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View.特发性肺纤维化患者的姑息治疗:肺科医生的观点。
J Pain Symptom Manage. 2020 Nov;60(5):933-940. doi: 10.1016/j.jpainsymman.2020.06.012. Epub 2020 Jun 20.
2
Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis.特发性肺纤维化急性加重的预后因素的系统评价和荟萃分析。
BMJ Open. 2020 Jun 15;10(6):e035420. doi: 10.1136/bmjopen-2019-035420.
3
Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials.
类风湿关节炎相关间质性肺疾病急性加重的发生率、风险因素和预后:系统评价和荟萃分析。
BMC Pulm Med. 2023 Jul 11;23(1):255. doi: 10.1186/s12890-023-02532-2.
4
Combination of computed tomography imaging pattern and severity of respiratory failure as factors associated with prognosis for acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia.计算机断层成像模式与呼吸衰竭严重程度作为特发性慢性纤维化间质性肺炎急性加重预后相关因素的研究。
PLoS One. 2023 Feb 24;18(2):e0279878. doi: 10.1371/journal.pone.0279878. eCollection 2023.
5
Naringin regulates endoplasmic reticulum stress and mitophagy through the ATF3/PINK1 signaling axis to alleviate pulmonary fibrosis.柚皮苷通过ATF3/PINK1信号轴调节内质网应激和线粒体自噬以减轻肺纤维化。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Jun;396(6):1155-1169. doi: 10.1007/s00210-023-02390-z. Epub 2023 Jan 23.
6
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.类风湿关节炎相关间质性肺疾病急性加重:死亡率及其预测模型。
Respir Res. 2022 Mar 11;23(1):57. doi: 10.1186/s12931-022-01978-y.
特发性肺纤维化(IPF)急性加重的不同严重程度:来自 INPULSIS®试验的见解。
Respir Res. 2019 Apr 11;20(1):71. doi: 10.1186/s12931-019-1037-7.
4
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
5
Prognostic significance of Glasgow prognostic score in patients with acute exacerbation of idiopathic pulmonary fibrosis.格拉斯哥预后评分对特发性肺纤维化急性加重患者的预后意义。
Respirology. 2018 Feb;23(2):206-212. doi: 10.1111/resp.13184. Epub 2017 Oct 12.
6
Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.特发性肺纤维化急性加重的管理中吸取的近期经验教训。
Eur Respir Rev. 2017 Sep 27;26(145). doi: 10.1183/16000617.0050-2017. Print 2017 Sep 30.
7
Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study.阿奇霉素治疗特发性肺纤维化特发性急性加重:一项回顾性单中心研究。
BMC Pulm Med. 2017 Jun 19;17(1):94. doi: 10.1186/s12890-017-0437-z.
8
Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.呼气末正压通气氧合对特发性肺纤维化急性加重期的预后评估:一项回顾性队列研究
Clin Respir J. 2018 Mar;12(3):895-903. doi: 10.1111/crj.12602. Epub 2017 Jan 12.
9
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.特发性肺纤维化急性加重:国际工作组报告。
Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75. doi: 10.1164/rccm.201604-0801CI.
10
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS(®) trials.尼达尼布治疗特发性肺纤维化患者:来自TOMORROW和INPULSIS(®)试验的综合证据。
Respir Med. 2016 Apr;113:74-9. doi: 10.1016/j.rmed.2016.02.001. Epub 2016 Feb 3.